Candesartan in Peripheral Neuropathy
NCT03688633
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class
Stopped
Patient Recruitment Failure
Conditions
Peripheral Neuropathy
Interventions
DRUG:
Candesartan
OTHER:
Usual care
Sponsor
University Hospital, Limoges